Presentation of the VHIR 2025 Annual Report

The report includes the centre's most relevant data and scientific and institutional results during the year.

04/08/2026

The Vall d’Hebron Research Institute (VHIR) has published its 2025 Annual Report, providing an overview of the institution’s main scientific and organisational achievements over the past year. Once again presented in a digital format, this year’s report features a design inspired by biomedical research and innovation, reflecting the institute’s core mission.

The Annual Report opens with an editorial by Dr Begoña Benito, Director of VHIR, who highlights the institution’s key milestones throughout 2025.

The report presents the most relevant figures on VHIR’s activity during the year, including scientific output, clinical trials, human resources, innovation, finance, and the work of the research support units. Among the highlights are more than 1,600 scientific publications, with 33.37% published in first-decile journals. During 2025, VHIR secured 197 new competitive grants, both national and international, to support research projects and fund research personnel. In the field of clinical research, 244 new studies were launched, bringing the total number of active studies to 1,088. The VHIR’s new scientific structure, organised into areas, COREs and programmes, to foster collaboration among research groups, is also introduced.

The report also includes dedicated sections exploring some of the institution’s major achievements in greater depth. It reviews the completion of the 2021–2025 Strategic Plan and the launch of NEUROAGE, a network coordinated by Vall d’Hebron to accelerate the impact of research on ageing and neurodegenerative diseases. In addition, the report highlights the main actions carried out under the Human Resources Strategy for Researchers (HRS4R) and presents the year's achievements of the Paediatric and Perinatal Research Hub. In addition, there are five videos showcasing the most outstanding scientific publications of the year, one for each CORE.

The report also features an overview of the activities of VHIR’s research groups, organised according to their respective research areas.

Finally, the Annual Report includes a summary of the institution’s most significant scientific and organisational news throughout 2025.

Consult the VHIR 2025 Annual Report

Share it:

Notícies relacionades

Related activities

Vall d'Hebron Talks by VHIR 'Revisiting the old paradigms in Sepsis: from "phases" to "patients"

09/14/2026 - 15:00
Vall d'Hebron Talks by VHIR
More information

Vall d'Hebron Talks by VHIR 'CRISPR Universe: where are today? From scissors to bridges'

10/05/2026 - 11:00
Vall d'Hebron Talks by VHIR
More information

Subscribe to our newsletters and be a part of Campus Life

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.